Which patients first? Setting priorities for antiretroviral therapy where resources are limited

American Journal of Public Health

Volumn 95, Issue 7, 2005, Pages 1173-1180

  McGough, Laura J ^a   Reynolds, Steven J ^b   Quinn, Thomas C ^b   Zenilman, Jonathan M ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; PENICILLIN G;

DECISION MAKING; DIABETES MELLITUS; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE NEED; HEMODIALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN RIGHTS; LIVER GRAFT; PRACTICE GUIDELINE; REVIEW;

HEALTH CARE AND PUBLIC HEALTH;

ADOLESCENT; ANTI-RETROVIRAL AGENTS; CHILD; DEVELOPING COUNTRIES; DIABETES MELLITUS, TYPE 1; HEALTH CARE RATIONING; HEALTH PRIORITIES; HIV INFECTIONS; HUMANS; INSULIN; LIVER TRANSPLANTATION; PATIENT SELECTION; PENICILLINS; PUBLIC HEALTH; RENAL DIALYSIS;

EID: 21644483328     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2004.052738     Document Type: Review

References (59)

1. World Health Organization, "'3 by 5' Progress Report December 2004," 2005, available at http://www.who.int/3by5/progressreport05/en, accessed January 27, 2005.
2. I b i d.
3. Ibid; "Treating 3 Million by 2005: Making It Happen: The WHO Strategy," available at http://www. unaids.org, accessed April 1, 2005.
4. R. B. Cheek, "Playing God With HIV: Rationing HIV Treatment in Southern Africa," African Security Review, 2001, available at http://www.iss.co.za/PUBS/ASR/10-No4/Cheek.html, accessed May 23, 2005.
5. L. Rosen, J. L. Simon, A. Collier, and I. M. Sanne, "Hard Choices: Rationing Antiretroviral Therapy for HIV/AIDS in Africa," Lancet 365 (2005): 354-356.
6. P. Piot, "Defeating HIV/AIDS: Africa Is Changing Gear," speech presented at closing ceremony of the International Conference on AIDS and STD in Africa, Nairobi, Kenya, September 26, 2003, available at http://www.unaids.org/ Unaids/EN/About+UNAIDS+ executive+director/unaids+executive+director/unaids+ executive+directors+speeches+.asp?StartRow=20, accessed May 23, 2005.
7. R. Macklin, "Ethics and Equity in Access to HIV Treatment-3 by 5 Initiative," background paper for the Consultation on Equitable Access to Treatment and Care for HIV/AIDS, World Health Organization, 2004, available at http://www.who.int/ethjcs/en/background-macklin3.pdf, accessed March 29, 2005;
8. N. Daniels, "How to Achieve Fair Distribution of ARTs in 3 by 5: Fair Process and Legitimacy in Patient Selection," background paper for the Consultation on Equitable Access to Treatment and Care for HIV/AIDS, World Health Organization, 2004, available at http://www.who.int/ethics/en/background- daniels3.pdf (accessed March 29, 2005);
9. Pro-Poor Health Policy Team, "'3 by 5,' Priority in Treatment, and the Poor," background paper for the Consultation on Equitable Access to Treatment and Care for HIV/AIDS, World Health Organization, 2004, available at http://www.who.int/ethics/en/background-pro-poor3.pdf (accessed March 29, 2005);
10. World Health Organization, "Guidance on Ethics and Equitable Access to HIV Treatment and Care," 2004, available at http://www.who.int/ethics/ en/ethics_equity_HIV_e.pdf (accessed March 29, 2005).
11. For historical background on the discovery of insulin and its treatment of diabetes, see M. Bliss, The Discovery of Insulin (Chicago: University of Chicago Press, 1982);
12. C. Feudtner, Bittersweet: Diabetes, Insulin, and the Transformation of Illness (Chapel Hill: University of North Carolina Press, 2003).
13. Ibid, 135,144,146,151.
14. For the history of penicillin rationing during World War II, see D.P. Adams, "The Greatest Good to the Greatest Number": Penicillin Rationing on the American Home Front, 1940-1945 (New York: Peter Lang, 1991).
15. Ibid, 70.
16. From the records of the Committee on Medical Research General Correspondence Files, quoted in Adams, "The Greatest Good to the Greatest Number," 71.
17. Adams, "The Greatest Good to the Greatest Number," 75.
18. Quoted in Adams, "The Greatest Good to the Greatest Number" 86.
19. Ibid, 74.
20. M. Leff, "The Politics of Sacrifice on the American Home Front in World War II," Journal of American History 77 (1991): 1296-1318.
21. H.M. Marks, "Cortisone, 1949: A Year in the Political Life of a Drug," Bulletin of the History of Medicine 66 (1992): 419-439.
22. For a historical background of hemodialysis, see Albert Jonsen, The Birth of Bioethics (Oxford: Oxford University Press, 1998);
23. S. Alexander "They Decide Who Lives, Who Dies," Life 53 (November 9, 1962): 102-125;
24. R.C. Fox and J.P Swazey, The Courage to Fail: A Social View of Organ Transplants and Dialysis, 2nd ed (Chicago: University of Chicago Press, 1978).
25. The lay members were a minister, a lawyer, a homemaker, a banker, a labor leader, a surgeon (who was not an expert in kidney disease), and a state government official. See Alexander, "They Decide Who Lives, Who Dies."
26. Ibid, 106.
27. Quoted in Fox and Swazey, The Courage to Fail, 232.
28. Alexander, "They Decide Who Lives, Who Dies," 106:
29. and R.C. Fox and J.P. Swazey, The Courage to Fail: A Social View of Organ Transplants and Dialysis (Chicago: University of Chicago Press, 1974), 245-246.
30. Fox and Swazey. The Courage to Fail, 241.
31. Quoted in Alexander, "They Decide Who Lives, Who Dies," 123.
32. R.W. Evans and C.R. Blagg, "Lessons Learned From the End-Stage Renal Disease Experience: Their Implications for Heart Transplantation," in Organ Substitution Technology: Ethical, Legal, and Public Policy Issues, ed. D. Mathieu (Boulder, Colo: Westview Press, 1988), 175-197.
33. D.W. Brock, "Ethical Issues in Recipient Selection for Organ Transplantation," in Organ Substitution Technology, 86-99.
34. For the Child-Turcotte-Pugh classification, see P.S. Kamath, R.H. Wiesner, M. Malinchoc. et al., "A Model to Predict Survival in Patients With End-Stage Liver Disease," Hepatology 33 (2001): 464-470.
35. P.A. Ubel and G. Loewenstein, "Distributing Scarce Livers: The Moral Reasoning of the General Public," Social Science and Medicine 42 (1996): 1049-1055.
36. A.J. Muir, L.L. Sanders, M.A. Heneghan, P.C. Kuo, W.E. Wilkinson, and D. Provenzale, "An Examination of Factors Predicting Prioritization for Liver Transplantation," Liver Transplantation 8 (2002): 957-961;
37. P.A. Ubel, R.M. Arnold, and A.L. Caplan, "Rationing Failure: The Ethical Lessons of the Retransplantation of Scarce Vital Organs," Journal of the American Medical Association 270 (1993): 2469-2474.
38. "Treating 3 Million by 2005," 31.
39. UNAIDS/WHO epidemiological fact sheet-2004 update; country-by-country search engine with HIV prevalence and incidence data available at http://www. who.int/GlobalAtlas/PDFFactory/H IV/index.asp (accessed March 29, 2005).
40. C. Wendo, "Uganda Begins Distributing Free Antiretrovirals," Lancet 363 (2004): 2062.
41. The countries are Botswana, Côte d'Ivoire, Ethiopia, Kenya, Mozambique, Namibia, Nigeria, Rwanda, South Africa, Tanzania, Uganda, Zambia, Guyana, Haiti, and Vietnam.
42. M. Rabkin, B. Tonwe-Gold, and W. El-Sadr, "Non-Medical Eligibility Criteria for Pilot HIV/AIDS Treatment Programs in Resource-Poor Settings: The Columbia University MTCT-Plus Experience," oral presentation, XV International AIDS Conference, July 14, 2004, Bangkok, Thailand, abstract WeOrB1278.
43. Christopher Kenyon, Jolene Skordis, Andrew Boulle, and Karrisha Pillay, "The ART of Rationing - The Need for a New Approach to Rationing Health Interventions," South African Medical Journal 93 (2003): 56-60;
44. M. Badri, L.G. Bekker, C. Orrell, J. Pitt, F. Cilliers, and R. Wood, "Initiating Highly Active Antiretroviral Therapy in sub-Saharan Africa: An Assessment of the Revised World Health Organization Scaling-Up Guidelines," AIDS 18 (2004): 1159-1168.
45. Louisana Lush and Ernest Darkoh, "HIV and Health Systems: Botswana," paper presented at 6th International Conference on Healthcare Resource Allocation for HIV/AIDS: Healthcare Systems in Transition, October 13-15, 2003, Washington, DC.
46. Ard van Sighem, Mark van de Wiel, Azra Ghani, et al., "Mortality and Progression to AIDS After Starting Highly Active Antiretroviral Therapy," AIDS 17 (2003): 2227-2236.
47. R. Murri, A. Antinori, A. Ammassari, et al., "Physician Estimates of Adherence and the Patient-Physician Relationship as a Setting to Improve Adherence to Antiretroviral Therapy," Journal of Acquired Immune Deficiency Syndrome 31 (2002): S158-S162.
48. I. Lanièce, M. Ciss, A. Desclaux, et al., "Adherence to HAART and Its Principal Determinants in a Cohort of Senegalese Adults," AIDS 17 supplement 3 (2003): S103-S108;
49. S. Weiser, W. Wolfe, D. Bangsberg, et al., "Barriers to Antiretroviral Adherence for Patients Living With HIV Infection and AIDS in Botswana," Journal of Acquired Immune Deficiency Syndrome 34 (2003): 281-288.
50. T. Kasper, D. Coetzee, F. Louis, A. Boulle, and K. Hilderbrand, "Demystifying Antiretroviral Therapy in Resource-Poor Settings," available at http://www.msf. org/content/page.cfm?articleid=3EC42CE5-ADDB-4384- BC25F9F03313DC04, accessed May 23, 2005.
51. Wendo, "Uganda Begins Distributing Free Antiretrovirals."
52. A. Waldman, "India Plans Free AIDS Therapy, But Effort Hinges on Price Accord With Drug Makers," New York Times, December 1, 2003. Available at http://www.aegis.eom/news/ads/2 003/AD032491. html, accessed May 23, 2005.
53. C. Bell, S. Devarajan, and H. Gersbach, "Thinking About the Long-Run Economic Costs of AIDS," in The Macroeconomics of HIV/AIDS, ed. M. Haacker (Washington: International Monetary Fund, 2004), 96-133.
54. L. Kapiriri, B. Robbestad, and O.F. Norheim, "The Relationship Between Prevention of Mother to Child Transmission of HIV and Stakeholder Decision Making in Uganda: Implications for Health Policy," Health Policy 66 (2003): 199-213.
55. Daniels, "How to Achieve Fair Distribution";
56. World Health Organization, "Guidance on Ethics and Equitable Access."
57. Stepping Back From the Edge: The Pursuit of Antiretroviral Therapy in Botswana, South Africa, and Uganda (Geneva: UNAIDS, April 2004).
58. R. Parker and P. Aggleton, "HIV and AIDS-Related Stigma and Discrimination," Social Science and Medicine 57 (2003): 13-24.
59. Cheek, "Playing God With HIV."